Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on 06/06/2018. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Baxter Healthcare
- Package NDC
- 0338-0072-25
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)
- Initial Posting
- 06/06/2018
- Revised Date
Reason
Other